The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample

BMC Geriatrics

Volumn 8, Issue , 2008, Pages

  Christensen, Helen ^a   Batterham, Philip J ^a   Mackinnon, Andrew J ^a,b   Jorm, Anthony F ^b   Mack, Holly A ^a   Mather, Karen A ^a   Anstey, Kaarin J ^a   Sachdev, Perminder S ^c,d   Easteal, Simon ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; COGNITIVE DEFECT; COMMUNITY SAMPLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HEAD INJURY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; RISK FACTOR; ALZHEIMER DISEASE; AUSTRALIA; CROSS-SECTIONAL STUDY; GENETICS; GERIATRIC ASSESSMENT; INTELLIGENCE TEST; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AUSTRALIA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GERIATRIC ASSESSMENT; HETEROZYGOTE; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 48349132829     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-8-14     Document Type: Article

References (34)

1. APOE genotype and cognitive functioning in a large age-stratified population sample. AF Jorm KA Mather P Butterworth KJ Anstey H Christensen S Easteal, Neuropsychology 2007 21 1 1 8 10.1037/0894-4105.21.1.1 17201525
2. Genetics of Alzheimer's Disease: A centennial review. N Ertekin-Taner, Neurologic clinics 2007 25 3 611 67, v 10.1016/j.ncl.2007.03.009 17659183
3. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. AM Saunders K Schmader JC Breitner MD Benson WT Brown L Goldfarb D Goldgaber MG Manwaring MH Szymanski N McCown KC Dole DE Schmechel WJ Strittmatter MA Pericak-Vance AD Roses, Lancet 1993 342 8873 710 711 10.1016/0140-6736(93)91709-U 8103823
4. APOE genotype influences acquisition and recall following traumatic brain injury. FC Crawford RD Vanderploeg MJ Freeman S Singh M Waisman L Michaels L Abdullah D Warden R Lipsky A Salazar MJ Mullan, Neurology 2002 58 7 1115 1118 11940706
5. Prospective study of alcohol consumption and risk of dementia in older adults. KJ Mukamal LH Kuller AL Fitzpatrick WT Longstreth Jr. MA Mittleman DS Siscovick, Journal of the American Medical Association 2003 289 11 1405 1413 10.1001/jama.289.11.1405 12636463
6. Relationships between cerebrovascular events, APOE polymorphism and Alzheimer's disease in a community sample. JM Johnston V Nazar-Stewart SF Kelsey MI Kamboh M Ganguli, Neuroepidemiology 2000 19 6 320 326 10.1159/000026271 11060506
7. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. JA Schneider JL Bienias RS Wilson E Berry-Kravis DA Evans DA Bennett, Stroke; a journal of cerebral circulation 2005 36 5 954 959 15774818
8. Change in cognitive functioning associated with apoE genotype in a community sample of older adults. SM Hofer H Christensen AJ Mackinnon AE Korten AF Jorm AS Henderson S Easteal, Psychology and aging 2002 17 2 194 208 10.1037/0882-7974.17.2.194
9. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. BJ Small H Basun L Backman, Psychology and aging 1998 13 1 80 87 10.1037/0882-7974.13.1.80
10. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. RS Wilson JA Schneider LL Barnes LA Beckett NT Aggarwal EJ Cochran E Berry-Kravis J Bach JH Fox DA Evans DA Bennett, Archives of Neurology 2002 59 7 1154 1160 10.1001/archneur.59.7.1154 12117364
11. Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. PM Greenwood T Sunderland JL Friz R Parasuraman, Proceedings of the National Academy of Sciences of the United States of America 2000 97 21 11661 11666 11027364 10.1073/pnas.97.21.11661
12. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. PM Greenwood C Lambert T Sunderland R Parasuraman, Neuropsychology 2005 19 2 199 211 15769204 10.1037/0894-4105.19.2.199
13. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. ER Peskind G Li J Shofer JF Quinn JA Kaye CM Clark MR Farlow C DeCarli MA Raskind GD Schellenberg VM Lee DR Galasko, Archives of Neurology 2006 63 7 936 939 10.1001/archneur.63.7.936 16831961
14. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. M Albert D Blacker MB Moss R Tanzi JJ McArdle, Neuropsychology 2007 21 2 158 169 10.1037/0894-4105.21.2.158 17402816
15. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. L Backman S Jones AK Berger EJ Laukka BJ Small, Neuropsychology 2005 19 4 520 531 10.1037/0894-4105.19.4.520 16060827
16. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. MW Bondi DP Salmon D Galasko RG Thomas LJ Thal, Psychology and aging 1999 14 2 295 303 10.1037/0882-7974.14.2. 295
17. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. MF Folstein SE Folstein PR McHugh, Journal of psychiatric research 1975 12 3 189 198 10.1016/0022-3956(75) 90026-6 1202204
18. Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. N Nathoo R Chetty JR van Dellen GH Barnett, Molecular Pathology 2003 56 3 132 136 12782758 10.1136/mp.56.3.132
19. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. R Mayeux SA Small M Tang B Tycko Y Stern, Neurobiology of aging 2001 22 4 683 689 10.1016/S0197-4580(01)00223-8 11445269
20. Gender differences in cognitive abilities: The mediating role of health state and health habits. AF Jorm KJ Anstey H Christensen B Rodgers, Intelligence 2004 32 545 548 10.1016/j.intell.2003.08.001
21. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. JE Hixson DT Vernier, Journal of lipid research 1990 31 3 545 548 2341813
22. A community survey demonstrated cohort differences in the lifetime prevalence of self-reported head injury. P Butterworth K Anstey AF Jorm B Rodgers, Journal of clinical epidemiology 2004 57 7 742 748 10.1016/j.jclinepi. 2003.10.015 15358403
23. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. JB Saunders OG Aasland TF Babor JR de la Fuente M Grant, Addiction (Abingdon, England) 1993 88 6 791 804 8329970
24. The Spot-the-Word Test. A Baddeley H Emslie I Nimmo-Smith, Bury St. Edmunds, United Kingdom, Thames Valley Test Company 1992
25. Symbol-Digit Modalities Test (SDMT) manual. A Smith, Los Angeles, CA, Western Psychological Services 1982
26. Biomarkers, health, lifestyle, and demographic variables as correlates of reaction time performance in early, middle, and late adulthood. KJ Anstey K Dear H Christensen AF Jorm, The Quarterly journal of experimental psychology 2005 58 1 5 21 15881288
27. California Verbal Learning Test. DC Delis JH Kramer E Kaplan BA Ober, San Antonio, TX, Psychological Corporation / Harcourt Brace Jovanovich 1987 3628618
28. A standardized memory scale for clinical use. D Wechsler, Journal of Psychology 1945 19 87 95
29. Prevalence of mild cognitive impairment in 60- to 64-year-old community-dwelling individuals: The Personality and Total Health through Life 60+ Study. R Kumar KB Dear H Christensen S Ilschner AF Jorm C Meslin SJ Rosenman PS Sachdev, Dementia and geriatric cognitive disorders 2005 19 2-3 67 74 10.1159/000082351
30. Mild cognitive impairment: clinical characterization and outcome. RC Petersen GE Smith SC Waring RJ Ivnik EG Tangalos E Kokmen, Arch Neurol 1999 56 3 303 308 10.1001/archneur.56.3.303 10190820
31. Age-associated memory impairment. Proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. T Crook RT Bartus SH Ferris P Whitehouse GD Cohen S Gershon, Developmental Neuropsychology 1986 2 261 276
32. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. R Levy, Int Psychogeriatr 1994 6 1 63 68 10.1017/S1041610294001626 8054494
33. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). American Psychiatric Association, Washington, DC, American Psychiatric Press, Inc. 1994
34. Genetic variation in memory functioning. LG Nilsson L Nyberg L Backman, Neuroscience & Biobehavioral Reviews 2002 26 7 841 848 10.1016/S0149- 7634(02)00070-2